Clinical utility and accessibility of functional precision medicine for relapsed/refractory pediatric and adult cancers. Article

Berlow, Noah, Acanda de la Rocha, Arlet M, Manrique-Succar, Jorge et al. (2024). Clinical utility and accessibility of functional precision medicine for relapsed/refractory pediatric and adult cancers. . JOURNAL OF CLINICAL ONCOLOGY, 42(16_suppl), 1551-1551. 10.1200/jco.2024.42.16_suppl.1551

cited authors

  • Berlow, Noah; Acanda de la Rocha, Arlet M; Manrique-Succar, Jorge; Coats, Ebony; Saghira, Cima; Espinal, Paula; Galano, Jeanette; Khatib, Ziad; Abdella, Haneen; Maher, Ossama; Andrade-Feraud, Cristina; Holcomb, Baylee; Ghurani, Yasmin; Rimblas, Lilliam; Guilarte, Tomas; Hu, Nan; Salyakina, Daria; Azzam, Diana

authors

publication date

  • June 1, 2024

published in

keywords

  • 3 Good Health and Well Being
  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 4.1 Discovery and preclinical testing of markers and technologies
  • 5.1 Pharmaceuticals
  • 6.1 Pharmaceuticals
  • Biotechnology
  • Cancer
  • Cancer Genomics
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Genetics
  • Health Disparities
  • Human Genome
  • Minority Health
  • Orphan Drug
  • Pediatric
  • Precision Medicine
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 1551

end page

  • 1551

volume

  • 42

issue

  • 16_suppl